Jacobs E

Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

8 papers · 2 preprints · ORCID

ArticlePsychedelics

As Psychedelic Treatments Get Leaner, Patients' Social Environments Deserve Attention.

Jacobs E, Roullier I, Watts R +1

Europe PMC2026
ArticlePsilocybin

Psychedelic medicine: mechanisms, evidence, and translation to practice.

Jacobs E, Zahid Z, Hinkle J +2

Europe PMC2026
ArticlePsychedelics

Analyzing the concept of independence in psychedelic research.

Cheung K, Ehrenkranz R, Earp BD +2

Europe PMC2026
ArticlePsilocybin

Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.

Rajwani K, Jacobs E, Bruce L +10

Europe PMC2025
PreprintPsilocybin

Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies

Rajwani K, Almonte MT, Feroz F +6

Europe PMC2025
ArticlePsychedelics

On Minimizing Risk and Harm in the Use of Psychedelics.

Evans J, Aixalà M, Anderson BT +28

Europe PMC2025
ArticlePsilocybin

UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.

Song-Smith C, Jacobs E, Rucker J +3

Europe PMC2024
PreprintPsychedelics

UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study

Song-Smith C, Jacobs E, Rucker J +3

Europe PMC2023
ArticlePsilocybin

When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.

Jacobs E, Murphy-Beiner A, Rouiller I +2

Europe PMC2024
ArticlePsychedelics

Transformative experience and informed consent to psychedelic-assisted psychotherapy.

Jacobs E

Europe PMC2023